This journal focuses on patent literature concerning the development of novel therapeutic agents, including small molecules, degraders, antibodies, and other modalities, targeting various biological pathways and enzymes for the treatment of diseases such as cancer, inflammatory disorders, neurodegenerative diseases, and metabolic disorders. The articles review recent patent activity, structural features, mechanisms of action, and clinical relevance of these therapeutic candidates.
Intellectual Property and PatentsDiverse Scientific and Economic StudiesLegal Cases and CommentaryReceptor Mechanisms and SignalingMonoclonal and Polyclonal Antibodies ResearchPeptidase Inhibition and AnalysisCholinesterase and Neurodegenerative DiseasesNeuropeptides and Animal PhysiologyCytokine Signaling Pathways and InteractionsNeuroscience and Neuropharmacology Research